CytoMed Therapeutics Ltd - Ordinary Shares, no par value per share (GDTC)

Historical Holders from Q2 2023 to Q4 2024

Symbol
GDTC on Nasdaq
CUSIP
Y1R80M106
Type / Class
Equity / Ordinary Shares, no par value per share
Shares outstanding
11.5M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
10.1K
Holdings value
$34.3K
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
1
Number of buys
1
Average Value change %
0%
Average buys %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CytoMed Therapeutics Ltd - Ordinary Shares, no par value per share (GDTC)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Choo Chee Kong 23.17% $5.88M 2.67M Choo Chee Kong Feb 20, 2025
mDR Ltd 11.33% $2.88M 1.31M mDR LTD Dec 16, 2024
28 Consultants Ltd 7.62% $1.94M 880K 28 Consultants Ltd Feb 17, 2025

Institutional Holders of CytoMed Therapeutics Ltd - Ordinary Shares, no par value per share (GDTC)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q4 10.1K $34.3K +$34.1K $3.40 1
2024 Q3 61 $96.00 +$96.00 $1.57 1
2024 Q2 0 $0 -$28 0
2024 Q1 13 $28.00 -$19K $2.15 1
2023 Q4 4.38K $21.5K +$134 $4.90 2
2023 Q3 5.88K $20.7K +$20.5K $3.51 2
2023 Q2 54 $165 +$165 $3.06 1